US Global Investors Funds’s Pfizer PFE Stock Holding History

US Global Investors Funds’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$199K	Buy	+6,851	New	+$199K	0.04%	255

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

US Global Investors Funds's PFE Position: Q4 2013 in Review

US Global Investors Funds opened a new position in Pfizer (PFE) in Q4 2013: 6,851 shares worth $199K. The stake represents 0.04% of the portfolio and ranks #255 among its holdings.

1,737 funds tracked by Wall St. Rank hold PFE as of Q4 2013.

US Global Investors Funds held 6,851 shares of Pfizer worth $199K as of Q4 2013.
Pfizer was a new US Global Investors Funds position in Q4 2013.
Pfizer made up 0.04% of US Global Investors Funds's portfolio in Q4 2013, its #255 holding.
1,737 funds tracked by Wall St. Rank held Pfizer as of Q4 2013.

Based on US Global Investors Funds's 13F filing for Q4 2013, filed 18 Feb 2014.